Favipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use, Lupin said in a regulatory filing. Its Covihalt dosage strength has been developed keeping in mind convenience of administration.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/31fGSUm
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Lupin launches coronavirus drug Favipiravir in India at Rs 49 per tablet
0 comments:
Post a Comment